- Exchange: Xetra
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Medigene AG (MDG)
| Open: | 0.892 | Day's Range: | 0.881 - 0.970 | Volume: | 162,371 |
|---|---|---|---|---|---|
| Previous Close: | 0.902 | 52wk Range: | 0.730 - 1.469 | 1-Yr Rtn: | -24.19% |
Key Statistics for MDG
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (EUR) (ttm) | -0.4300 |
| Est. EPS (EUR) (12/2013) | -0.2830 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 34.86 |
| Shares Outstanding (M) | 37.08 |
| 30 Day Average Volume | 110,146 |
| Price/Book (mrq) | 0.8502 |
| Price/Sale (ttm) | 10.0745 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for MDG
Company Profile & Key Executives for MDG
Medigene AG operates as a biopharmaceutical company. The Company provides research, development, and commercialization of drugs for the treatment of cancer and autoimmune diseases.
| Frank MathiasCEO/Member-Mgmt Board | Peter Llewellyn-DaviesCFO/Member-Mgmt Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
MDG News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page